Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’
Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’
About this item
Full title
Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Annals of the rheumatic diseases, 2023-04, Vol.82 (4), p.e81-e81
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Alternative Titles
Full title
Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2483815676
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2483815676
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2021-219872
